Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,926.00    4.00 (0.21%)
Bid:
1,925.00
Ask:
1,927.00
Spread: 2.00 (0.104%)
Market Cap: £3.23b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Directorate Change

9 Sep 2024 07:00

RNS Number : 3088D
Johnson Matthey PLC
09 September 2024
 

9th September 2024

 

Johnson Matthey Plc

(the Company)

Sinead Lynch to join Johnson Matthey as a Non-Executive Director

 

The Company is pleased to announce the appointment of Sinead Lynch as an independent Non-Executive Director with effect from 1st January 2025. Sinead will also become a member of the Remuneration, Nomination and Societal Value Committees.

 

Sinead brings a deep understanding of low carbon energy and sustainability, having spent 30 years in the energy sector at Royal Dutch Shell ("Shell") and BG Group ("BG"), including the last 10 years in an executive capacity. Most recently, she led Shell's Low Carbon Fuels business, developing technologies and investing in projects to produce sustainable renewable fuels at scale. Prior to this, Sinead was the UK Country Chair at Shell and led the Safety and Sustainability division of BG before its acquisition by Shell. She was also co-chair of the UK Hydrogen Advisory Council from 1st July 2020 until 1st August 2021.

 

Following a seven-year tenure, Jane Griffiths has taken the decision to step down as Chair of the Societal Value Committee and from the Board on 31st December 2024. Rita Forst will succeed Jane as Chair of the Societal Value Committee from 1st January 2025.

 

 

 

Patrick Thomas, Chair of Johnson Matthey said:

 

"On behalf of the Board, I would like to thank Jane for her significant contributions during her time with Johnson Matthey. In particular, her input and challenge to our sustainability commitments has been invaluable, and I wish her well for the future. I'm very pleased to welcome Sinead to the Board and look forward to benefiting from her expertise and advice, as JM continues to transform into an industry-leading energy transition company."

 

 

There are no further matters to be disclosed pursuant to UK Listing Rule 6.4.8R

 

 

ENDS

 

Enquiries: 

 

Simon Price

General Counsel and Company Secretary

+44 20 7269 8052

Martin Dunwoodie

Director of Investor Relations

+44 20 7269 8241

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGGLVVRGDZM
Date   Source Headline
11th Mar 20227:00 amRNSTransaction in Own Shares
10th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:00 amRNSTransaction in Own Shares
8th Mar 20227:00 amRNSTransaction in Own Shares
7th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20227:00 amRNSTransaction in Own Shares
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20227:00 amRNSTransaction in Own Shares
1st Mar 20222:58 pmRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 202211:37 amRNSTotal Voting Rights
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 202212:39 pmRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSShare buyback programme
11th Feb 202212:28 pmRNSDirector/PDMR Shareholding
11th Feb 202212:13 pmRNSDirector/PDMR Shareholding
10th Feb 202211:47 amRNSAppointment of joint corporate broker
7th Feb 20228:00 amRNSJohnson Matthey Clean Air roundtable
1st Feb 20228:00 amRNSTotal Voting Rights
1st Feb 20227:00 amRNSAdvanced Glass Technologies sale completion
28th Jan 20225:44 pmRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
27th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:00 amRNSTransaction in Own Shares
25th Jan 20227:00 amRNSTransaction in Own Shares
24th Jan 20227:00 amRNSTransaction in Own Shares
21st Jan 20223:32 pmRNSDirector/PDMR Shareholding
21st Jan 20227:00 amRNSTransaction in Own Shares
20th Jan 20223:35 pmRNSHolding(s) in Company
20th Jan 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSTransaction in Own Shares
18th Jan 20227:00 amRNSTransaction in Own Shares
17th Jan 20227:00 amRNSTransaction in Own Shares
14th Jan 20227:00 amRNSTransaction in Own Shares
13th Jan 202210:00 amRNSHolding(s) in Company
13th Jan 20227:00 amRNSTransaction in Own Shares
12th Jan 20222:19 pmRNSJohnson Matthey Battery Materials update
12th Jan 20227:00 amRNSTransaction in Own Shares
11th Jan 202211:45 amRNSDirector/PDMR Shareholding
11th Jan 20227:00 amRNSTransaction in Own Shares
10th Jan 202212:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.